Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of NanoDOX Hydrogel vs Placebo for Dehisced Surgical Wounds

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborator:
United States Department of Defense
Information provided by (Responsible Party):
Nanotherapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT01547325
First received: February 24, 2012
Last updated: June 6, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)